Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | FTRE | CSTL | ||
| Company | Urogen Pharma Ltd | Fortrea Holdings Inc | Castle Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 20.26 | 10.29 | 31.84 | ||
| High | 21.62 | 10.58 | 33.66 | ||
| Low | 20.14 | 9.86 | 31.84 | ||
| Latest | 20.30 | 10.07 | 33.03 | ||
| Change | +0.09 | -0.20 | +1.13 | ||
| % Change | +0.45% | -1.95% | +3.54% | ||
| Volume | 518,937 | 1,283,040 | 115,299 | ||
| 20-Day Average Volume | 660,787 | 1,634,698 | 404,456 | ||
| Previous Close | 20.21 | 10.27 | 31.90 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 20.48 | 15.32 | 37.53 | ||
| 20-Day Raw Stochastic | 56.87% | 10.69% | 13.26% | ||
| 20-Day Relative Strength | 46.88 | 29.48 | 36.54 | ||
| Weighted Alpha | +45.84 | -11.95 | +14.60 | ||
| Today's Opinion | 8% Buy | 8% Buy | 24% Buy | ||
| Previous Opinion | 8% Sell | 8% Buy | 24% Buy | ||
| Last Month's Opinion | 8% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.12% since 02/06/26 | -30.92% since 02/06/26 | +1.04% since 02/06/26 | ||
| Low | 19.65 on 02/12/26 | 9.20 on 02/12/26 | 31.38 on 02/11/26 | ||
| High | 22.25 on 02/10/26 | 15.00 on 02/09/26 | 33.60 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | +3.23% since 01/13/26 | -41.74% since 01/13/26 | -16.52% since 01/13/26 | ||
| Low | 18.12 on 01/14/26 | 9.20 on 02/12/26 | 31.38 on 02/11/26 | ||
| High | 22.25 on 02/10/26 | 17.81 on 01/22/26 | 44.28 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | -14.42% since 11/13/25 | -0.98% since 11/13/25 | -3.02% since 11/13/25 | ||
| Low | 18.12 on 01/14/26 | 9.20 on 02/12/26 | 31.38 on 02/11/26 | ||
| High | 30.00 on 11/26/25 | 18.67 on 01/06/26 | 44.28 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +1.79% since 08/13/25 | +29.08% since 08/13/25 | +70.48% since 08/13/25 | ||
| Low | 15.86 on 10/10/25 | 7.40 on 08/21/25 | 18.99 on 08/14/25 | ||
| High | 30.00 on 11/26/25 | 18.67 on 01/06/26 | 44.28 on 01/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 946,010 | 948,948 | 931,129 | ||
| Shares Outstanding, K | 46,809 | 92,400 | 29,189 | ||
| Annual Sales | 90,400,000 | 2,696,400,000 | 332,070,000 | ||
| Annual Net Income | -126,870,000 | -328,500,000 | 18,250,000 | ||
| Last Quarter Sales | 27,480,000 | 701,300,000 | 83,040,000 | ||
| Last Quarter Net Income | -33,350,000 | -15,900,000 | -500,000 | ||
| 60-Month Beta | 1.32 | 1.59 | 1.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.69 on 11/06/25 | 0.12 on 11/05/25 | -0.02 on 11/03/25 | ||
| Latest Earnings Date | 03/09/26 | 02/26/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.73 | 129.36 | ||